WOCKPHARMA — Wockhardt Share Price
0.000.00%
Last trade - 00:00- IN₹227.09bn
- IN₹251.47bn
- IN₹27.98bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.69 | ||
| Price to Tang. Book | 23.98 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 7.65 | ||
| EV to EBITDA | 93.48 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.9% | ||
| Return on Equity | -5.86% | ||
| Operating Margin | 1.58% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 28,439.9 | 27,083 | 32,300 | 26,510 | 27,980 | n/a | n/a | -4.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and supplies branded and generic finished formulations, as well as intermediate products like active pharmaceutical ingredients (APIs), worldwide. The Company’s products in India include EMROK, MERIWOK, REINVEXIN, ERLISO, METHYCOBAL TABLET, METHYCOBAL INJ, METHYCOBAL D, HAPID, PROXYFEN NANO GEL, LIVATIRA TABLET, LIVATIRA INJ, GABAWOK NT 100, GABAWOK NT 400, ETOBRIX 90, ETOBRIX TH4, ETOBRIX P, GLARZEN CARTRIDGE, GLARZEN DISPOPEN 2, ESOWOK D, TERITIDE, GLIMADAY, SITAWOK, GLARITUS, TRIMETADAY, MOPADAY, INOGLA, and ZINODAP. The Company has manufacturing and research facilities in India, United States of America and the United Kingdom and a manufacturing facility in Ireland.
Directors
- Habil Fakhruddin Khorakiwala CHM (77)
- Debashis Dey CCO
- Murtaza Habil Khorakiwala MDR
- Huzaifa Habil Khorakiwala EDR
- Rima Marphatia DRC
- Zahabiya Habil Khorakiwala NED
- Sanjaya Baru NID
- Davinder Brar NID
- Akhilesh Gupta NID
- Vinesh Jairath NID
- Aman Mehta NID (75)
- Tasneem Mehta NID (66)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 8th, 1999
- Public Since
- February 25th, 1994
- No. of Shareholders
- 150,292
- No. of Employees
- 2,394
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 162,485,569
- Address
- Wockhardt Towers, MUMBAI, 400051
- Web
- https://www.wockhardt.com/
- Phone
- +91 2226534444
- Auditors
- BSR & Co. LLP
Upcoming Events for WOCKPHARMA
Wockhardt Ltd Annual Shareholders Meeting
Q1 2026 Wockhardt Ltd Earnings Release
Similar to WOCKPHARMA
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Wockhardt share price?
As of Today at 06:07 UTC, shares in Wockhardt are trading at IN₹1,397.60. This share price information is delayed by 15 minutes.
How has the Wockhardt share price performed this year?
Shares in Wockhardt last closed at IN₹1,397.60 and the price had moved by +144.91% over the past 365 days. In terms of relative price strength the Wockhardt share price has outperformed the S&P BSE 100 Index by +130.71% over the past year.
What are the analyst and broker recommendations for Wockhardt?
There is no consensus recommendation for this security.
Find out moreWhat is the Wockhardt dividend yield?
Wockhardt does not currently pay a dividend.
Does Wockhardt pay a dividend?
Wockhardt does not currently pay a dividend.
When does Wockhardt next pay dividends?
Wockhardt does not currently pay a dividend.
How do I buy Wockhardt shares?
To buy shares in Wockhardt you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Wockhardt?
As of the previous close price of IN₹1,397.60, shares in Wockhardt had a market capitalisation of IN₹227.09bn.
Where are Wockhardt shares listed?
Here are the trading details for Wockhardt:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: WOCKPHARMA
What kind of share is Wockhardt?
Based on an overall assessment of its quality, value and momentum Wockhardt is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Wockhardt share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Wockhardt share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Wockhardt. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +33.79%.
As of the last closing price of IN₹1,397.60, shares in Wockhardt were trading +15.47% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Wockhardt PE Ratio?
The Wockhardt PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹1,397.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Wockhardt?
Wockhardt's management team is headed by:
- Habil Fakhruddin Khorakiwala - CHM
- Debashis Dey - CCO
- Murtaza Habil Khorakiwala - MDR
- Huzaifa Habil Khorakiwala - EDR
- Rima Marphatia - DRC
- Zahabiya Habil Khorakiwala - NED
- Sanjaya Baru - NID
- Davinder Brar - NID
- Akhilesh Gupta - NID
- Vinesh Jairath - NID
- Aman Mehta - NID
- Tasneem Mehta - NID